相关实验视频

Updated: May 22, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

对Ra223的预后因素进行多中心,国际,回顾性研究

Takuya Oishi¹, Hao-Lun Luo², Yoshiomi Hatayama³

¹Department of Urology, Hirosaki University Graduate of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan.

Scientific reports

|March 29, 2025

概括

这项研究验证了二二 (Ra223) 治疗转移性割抵抗性前列腺癌 (mCRPC) 患者的风险模型. 识别风险因素可以帮助预测整体存活率和治疗完成率,改善患者的治疗结果.

科学领域:

在瘤学瘤学.
放射性药物疗法是一种放射性药物疗法.
前列腺癌研究研究前列腺癌

背景情况:

在转移性割抵抗性前列腺癌 (mCRPC) 中治疗二二化 (Ra223) 的预后因素需要进一步澄清.
准确的风险分层对于优化mCRPC患者的Ra223治疗至关重要.

研究的目的:

验证一个现有的风险模型,用于预测mCRPC患者的整体存活率 (OS) 差和Ra223治疗周期不完整.
开发一种国际风险模型,以提高Ra223处理的mCRPC的预后准确度.

主要方法:

在日本和台湾接受Ra223治疗的345名mCRPC患者的回顾性分析 (R2D2研究).
在2016年8月至2023年10月期间,评估了骨转移占主导地位的mCRPC患者.
建立了开发和验证队列 (分别为71名和274名患者).

主要成果:

一个不良OS的风险模型确定了表现不佳的状态,Ra223 6周期不完整性和PSA> 10 ng/mL作为关键因素.
对于Ra223 6周期不完整的风险模型包括先前的mCRPC治疗> 2和骨转移 (EOD) 的程度 3-4.
在验证队列中,风险因素的数量 (0-1 vs. 2-3) 与OS有显著的相关性.

结论:

经过验证的风险模型有效预测了接受Ra223.3的mCRPC患者的结果.
鉴定的风险因素可能与有利的生存率有关,指导治疗决策.
这项研究有助于更好地评估前列腺癌放射性药物治疗的预后.

关键词:

耐化的防.转移性转移性前列腺癌是什么意思前列腺癌是什么意思 -2233是一种.风险因素风险因素风险因素幸存的生存方式

更多相关视频

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

相关概念视频

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...